Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $720.39 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $159.87 | 7 | $0 (2024) |
| Allergan Inc. | $90.46 | 3 | $0 (2018) |
| AbbVie, Inc. | $74.76 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $74.15 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $58.45 | 3 | $0 (2024) |
| VIVUS LLC | $34.61 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $29.94 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $26.50 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $22.21 | 1 | $0 (2020) |
| Braintree Laboratories, Inc. | $20.93 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204.72 | 9 | Janssen Biotech, Inc. ($77.75) |
| 2023 | $137.45 | 7 | Janssen Biotech, Inc. ($61.20) |
| 2022 | $20.92 | 1 | Janssen Biotech, Inc. ($20.92) |
| 2021 | $94.83 | 5 | VIVUS LLC ($21.55) |
| 2020 | $50.44 | 3 | Astellas Pharma US Inc ($22.21) |
| 2019 | $14.38 | 1 | Lundbeck LLC ($14.38) |
| 2018 | $62.59 | 4 | AbbVie, Inc. ($37.90) |
| 2017 | $135.06 | 5 | Allergan Inc. ($79.22) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Gastroenterology | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Immunology | ||||||
| 07/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Endocrinology | ||||||
| 04/23/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Immunology | ||||||
| 03/05/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/12/2023 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/10/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/01/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Immunology | ||||||
| 09/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Gastroenterology | ||||||
| 08/24/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Immunology | ||||||
| 06/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/19/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Immunology | ||||||
| 03/16/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Immunology | ||||||
| 12/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/14/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: GI COLON PREP | ||||||
| 08/23/2021 | VIVUS LLC | Qsymia (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/12/2021 | Trevena, Inc. | Olinvyk (Drug) | Food and Beverage | Cash or cash equivalent | $15.68 | General |
| Category: Pain Management | ||||||
| 03/23/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/15/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: UROLOGY | ||||||
| 10/12/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2020 | RedHill Biopharma Inc. | Aemcolo (Drug), Movantik, Talicia | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Antibiotic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 251 | 257 | $666,080 | $30,769 |
| 2022 | 4 | 282 | 288 | $495,048 | $33,473 |
| 2021 | 4 | 252 | 255 | $341,872 | $28,284 |
| 2020 | 4 | 274 | 280 | $239,108 | $31,807 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 109 | 111 | $302,800 | $13,241 | 4.4% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 70 | 71 | $214,080 | $9,097 | 4.2% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 56 | 59 | $120,160 | $6,628 | 5.5% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 16 | 16 | $29,040 | $1,802 | 6.2% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 109 | 110 | $176,544 | $11,941 | 6.8% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 69 | 70 | $139,440 | $9,367 | 6.7% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 79 | 82 | $138,696 | $9,266 | 6.7% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 25 | 26 | $40,368 | $2,900 | 7.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 87 | 87 | $107,372 | $9,171 | 8.5% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 79 | 82 | $107,660 | $9,081 | 8.4% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 52 | 52 | $84,128 | $6,612 | 7.9% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 34 | 34 | $42,712 | $3,419 | 8.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 87 | 90 | $77,468 | $10,275 | 13.3% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 89 | 91 | $75,800 | $9,563 | 12.6% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 46 | 47 | $47,020 | $6,167 | 13.1% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 52 | 52 | $38,820 | $5,802 | 14.9% |
About Dr. Michael Moore, M.D
Dr. Michael Moore, M.D is a Anesthesiology healthcare provider based in Haleyville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639120447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Moore, M.D has received a total of $720.39 in payments from pharmaceutical and medical device companies, with $204.72 received in 2024. These payments were reported across 35 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($720.39).
As a Medicare-enrolled provider, Moore has provided services to 1,059 Medicare beneficiaries, totaling 1,080 services with total Medicare billing of $124,334. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Haleyville, AL
- Active Since 05/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639120447
Products in Payments
- STELARA (Biological) $106.48
- NATRELLE-INSPIRA (Device) $66.75
- ENTYVIO (Biological) $57.44
- TREMFYA (Drug) $53.39
- XIFAXAN (Drug) $53.35
- Creon (Drug) $52.86
- DUPIXENT (Biological) $29.94
- DIFICID (Drug) $26.50
- TRULANCE (Drug) $24.08
- MYRBETRIQ (Drug) $22.21
- Humira (Biological) $21.90
- Qsymia (Drug) $21.55
- SUTAB (Drug) $20.93
- OCALIVA (Drug) $20.36
- GATTEX (Drug) $16.71
- Dexcom G6 Transmitter (Medical Supply) $16.54
- Olinvyk (Drug) $15.68
- ZENPEP (Drug) $15.48
- NORTHERA (Drug) $14.38
- Aemcolo (Drug) $13.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.